Pro Pharmaceutical Co., Ltd. has proposed a stock option incentive plan for 2026 aimed at attracting and retaining key management and technical personnel. The plan includes granting 7,597,000 stock options, representing 0.66% of the company's total share capital. The exercise price is set at 13.38 yuan per share, with a maximum validity of 60 months. The plan requires shareholder approval before implementation.
Summary generated by AI · Always verify with source document
The company and all directors guarantee that the content of this incentive plan and its summary is true, accurate, and complete, with no false records, misleading statements, or significant omissions. All incentive recipients commit to returning all benefits obtained from this incentive plan if the company suffers losses due to false records, misleading statements, or significant omissions in the information disclosure documents.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.